Ju Z, Sun W. Drug delivery vectors based on filamentous bacteriophages and phage-mimetic nanoparticles. Drug Deliv. 2017;24:1898–908.
Article CAS PubMed PubMed Central Google Scholar
Ma Y, Nolte RJ, Cornelissen JJ. Virus-based nanocarriers for drug delivery. Adv Drug Deliv Rev. 2012;64:811–25.
Article CAS PubMed Google Scholar
Guimarães D, Cavaco-Paulo A, Nogueira E. Design of liposomes as drug delivery system for therapeutic applications. Int J Pharmaceut. 2021. https://doi.org/10.1016/j.ijpharm.2021.120571.
Ullah A, Wang K, Wu P, Oupicky D, Sun M. <p>CXCR4-targeted liposomal mediated co-delivery of pirfenidone and AMD3100 for the treatment of TGFβ-induced HSC-T6 cells activation</p>. Int J Nanomed. 2019;14:2927–44.
Pugazhendhi A, Edison T, Karuppusamy I, Kathirvel B. Inorganic nanoparticles: a potential cancer therapy for human welfare. Int J Pharm. 2018;539:104–11.
Article CAS PubMed Google Scholar
Gao J, Wang W-Q, Pei Q, Lord MS, Yu H-J. Engineering nanomedicines through boosting immunogenic cell death for improved cancer immunotherapy. Acta Pharmacol Sin. 2020;41:986–94.
Article CAS PubMed PubMed Central Google Scholar
Jeon M, Lin G, Stephen ZR, Kato FL, Zhang M. Paclitaxel-loaded iron oxide nanoparticles for targeted breast cancer therapy. Adv Ther. 2019. https://doi.org/10.1002/adtp.201900081.
Vines JB, Yoon JH, Ryu NE, Lim DJ, Park H. Gold nanoparticles for photothermal cancer therapy. Front Chem. 2019;7:167.
Article CAS PubMed PubMed Central Google Scholar
Maksoudian C, Saffarzadeh N, Hesemans E, Dekoning N, Buttiens K, Soenen SJ. Role of inorganic nanoparticle degradation in cancer therapy. Nanoscale Adv. 2020;2:3734–63.
Article CAS PubMed PubMed Central Google Scholar
Lohcharoenkal W, Wang L, Chen YC, Rojanasakul Y. Protein nanoparticles as drug delivery carriers for cancer therapy. Biomed Res Int. 2014;2014:180549.
Article PubMed PubMed Central Google Scholar
Miao Y, Yang T, Yang S, Yang M, Mao C. Protein nanoparticles directed cancer imaging and therapy. Nano Converg. 2022;9:2.
Article CAS PubMed PubMed Central Google Scholar
Kaur T, Nafissi N, Wasfi O, Sheldon K, Wettig S, Slavcev R. Immunocompatibility of bacteriophages as nanomedicines. J Nanotechnol. 2012;2012:1–13.
Dion MB, Oechslin F, Moineau S. Phage diversity, genomics and phylogeny. Nat Rev Microbiol. 2020;18:125–38.
Article CAS PubMed Google Scholar
Monteiro R, Pires DP, Costa AR, Azeredo J. Phage therapy: going temperate? Trends Microbiol. 2019;27:368–78.
Article CAS PubMed Google Scholar
Hsu BB, Way JC, Silver PA. Stable neutralization of a virulence factor in bacteria using temperate phage in the mammalian gut. mSystems. 2020. https://doi.org/10.1128/mSystems.00013-20.
Article PubMed PubMed Central Google Scholar
Huh H, Wong S, St Jean J, Slavcev R. Bacteriophage interactions with mammalian tissue: therapeutic applications. Adv Drug Deliv Rev. 2019;145:4–17.
Article CAS PubMed Google Scholar
Ulfo L, Cantelli A, Petrosino A, Costantini PE, Nigro M, Starinieri F, Turrini E, Zadran SK, Zuccheri G, Saporetti R, Di Giosia M, Danielli A, Calvaresi M. Orthogonal nanoarchitectonics of M13 phage for receptor targeted anticancer photodynamic therapy. Nanoscale. 2022;14:632–41.
Article CAS PubMed Google Scholar
Smith GP, Petrenko VA. Phage display. Chem Rev. 1997;97:391–410.
Article CAS PubMed Google Scholar
Peng H, Borg RE, Dow LP, Pruitt BL, Chen IA. Controlled phage therapy by photothermal ablation of specific bacterial species using gold nanorods targeted by chimeric phages. Proc Natl Acad Sci U S A. 2020;117:1951–61.
Article CAS PubMed PubMed Central Google Scholar
Ghosh D, Kohli AG, Moser F, Endy D, Belcher AM. Refactored M13 bacteriophage as a platform for tumor cell imaging and drug delivery. ACS Synth Biol. 2012;1:576–82.
Article CAS PubMed PubMed Central Google Scholar
Foglizzo V, Marchio S. Bacteriophages as therapeutic and diagnostic vehicles in cancer. Pharmaceuticals (Basel). 2021. https://doi.org/10.3390/ph14020161.
Jiang H, Li Y, Cosnier S, Yang M, Sun W, Mao C. Exploring phage engineering to advance nanobiotechnology. Mater Today Nano. 2022. https://doi.org/10.1016/j.mtnano.2022.100229.
D’Herelle F. On an invisible microbe antagonistic toward dysenteric bacilli: brief note by Mr. F. D’Herelle, presented by Mr. Roux. 1917. Res Microbiol. 2007;158:553–4.
Sunderland KS, Yang M, Mao C. Phage-enabled nanomedicine: from probes to therapeutics in precision medicine. Angew Chem Int Ed Engl. 2017;56:1964–92.
Article CAS PubMed PubMed Central Google Scholar
Zhang W, Hu E, Wang Y, Miao S, Liu Y, Hu Y, Liu J, Xu B, Chen D, Shen Y. Emerging antibacterial strategies with application of targeting drug delivery system and combined treatment. Int J Nanomed. 2021;16:6141–56.
Branston SD, Wright J, Keshavarz-Moore E. A non-chromatographic method for the removal of endotoxins from bacteriophages. Biotechnol Bioeng. 2015;112:1714–9.
Article CAS PubMed Google Scholar
Kondratova L, Kondratov O, Ragheb R, Zolotukhin S. Removal of endotoxin from rAAV samples using a simple detergent-based protocol. Mol Ther Methods Clin Dev. 2019;15:112–9.
Article CAS PubMed PubMed Central Google Scholar
Li Y, Guo Y, Aoqi L, Ma C, Xiong Z, Yuan D, Zhang C, Zhang J, Dun Y. Changes of colon in rats with different ages in response to lipopolysaccharide. Curr Med Chem. 2023;30:4492–503.
Article CAS PubMed Google Scholar
Hodyra-Stefaniak K, Miernikiewicz P, Drapala J, Drab M, Jonczyk-Matysiak E, Lecion D, Kazmierczak Z, Beta W, Majewska J, Harhala M, Bubak B, Klopot A, Gorski A, Dabrowska K. Mammalian Host-Versus-Phage immune response determines phage fate in vivo. Sci Rep. 2015;5:14802.
Article CAS PubMed PubMed Central Google Scholar
Kim BO, Kim ES, Yoo YJ, Bae HW, Chung IY, Cho YH. Phage-derived antibacterials: harnessing the simplicity plasticity, and diversity of phages. Viruses. 2019;11:268.
Article CAS PubMed PubMed Central Google Scholar
Skurnik M, Pajunen M, Kiljunen S. Biotechnological challenges of phage therapy. Biotechnol Lett. 2007;29:995–1003.
留言 (0)